Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis
详细信息查看全文 | 推荐本文 |
摘要
| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Background

Pulmonary sarcoidosis is frequently characterized by a CD4+/CD8+ ratio 鈮?.5 in bronchoalveolar lavage fluid (BALF), although up to 40%of the cases present a normal or even decreased ratio, pointing out its variability and limitation as a diagnostic marker for sarcoidosis. Lung lymphocytes within the bronchial epithelium, the alveolar walls, and BALF express the integrin CD103. Our aim was to compare the expression of CD103 in BALF T-lymphocytes between sarcoidosis and other interstitial lung diseases (ILD) and to evaluate its relevance as a BALF diagnostic marker for sarcoidosis.

Methods

A total of 86 patients with ILD (mean age聽卤聽standard deviation, 42.6聽卤聽16.6 years; 60.5%female), who underwent BALF as part of their initial diagnostic work-up, were enrolled into 2 groups: sarcoidosis (n聽=聽41) and other ILD (n聽=聽45). Area under the receiver operating characteristic (ROC) curve (AUC) was used to describe the performance of CD103 for sarcoidosis diagnosis.

Results

Sarcoidosis patients presented a significantly reduced CD103 expression in BALF T-lymphocytes, more pronounced in the CD4+ subset. The BALF CD103+CD4+/CD4+ ratio for a cutoff point of 0.45 was associated with a better diagnostic performance for sarcoidosis (AUC: 0.86 [95%confidence interval (95%CI): 0.78-0.94]; sensitivity: 81%; specificity: 78%), even for those with a CD4+/CD8+ ratio <3.5 (AUC: 0.79 [95%CI: 0.64-0.93]; sensitivity: 75%; specificity: 78%).

Conclusions

Assessment of CD103 expression in BALF CD4+ T-lymphocytes may be a reliable tool for sarcoidosis diagnosis, independently of CD4+/CD8+ ratio, pointing out the relevance of evaluating the CD103+CD4+/CD4+ ratio in the ILD diagnostic work-up.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700